Safety and efficacy of ibrutinib in a patient with severe renal impairment
Hematol Rep
.
2017 Sep 26;9(3):7078.
doi: 10.4081/hr.2017.7078.
Authors
Kalman Filanovsky
1
,
Lev Shvidel
1
Affiliation
1
Kaplan Medical Center, Rehovot; Hadassah and Hebrew University Medical School, Jerusalem, Israel.
PMID:
29071051
PMCID:
PMC5641823
DOI:
10.4081/hr.2017.7078
No abstract available
Keywords:
chronic renal failure; ibrutinib; lymphoma.
Publication types
Editorial